Physician profile
Michael A Kling
NPI 1235214479
$5,781.69
in general payments reported to CMS, 2019-2025
17 companies · $685 in 2025
The $685 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $700 · 2021: $737 · 2022: $2,021 · 2023: $554 · 2024: $487 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449 · Entertainment: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.48 |
| Entertainment | $276.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,375.75 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $691.03 | 2020-2021 | |
| Maculogix, INC. | $406.79 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $339.54 | 2022-2025 | Infuse |
| Sight Sciences, INC. | $319.99 | 2019-2023 | Tearcare System |
| Lumenis Be INC | $294.20 | 2022-2024 | Optilight |
| Optos, INC. | $276.34 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $263.21 | 2019-2023 | Dailies |
| Lkc Technologies, INC. | $254.04 | 2023-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $174.98 | 2019-2021 | |
| Ocular Therapeutix, INC. | $125.00 | 2021 | |
| Lombart Brothers, INC. | $103.79 | 2025 | Opd-III |
| Abb Con-Cise Optical Group LLC | $66.67 | 2024 | Spectacle Lenses, Contact Lens |
| Oyster Point Pharma, INC. | $25.27 | 2023 | Tyrvaya |
| Abbvie INC. | $25.00 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $21.84 | 2021 | |
| Optovue, INC. | $18.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.